Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
Friday, July 29, 2022 |
|
7:00am | Check-in & Breakfast Available in Exhibit Hall |
8:00am | Horizon CME App Overview |
8:10am | Welcome, Introductions, & CE Housekeeping |
8:15am | (01) Financial Toxicity of Cancer Care: How Can We Assist Patients? » Jason Astrin, DMSc, MBA, PA-C, DFAAPA - The US Oncology Network |
9:15am | (02) Provider Burnout: Is Resilience the Answer? » Erin Kopp, MSN, ACNP-BC, NP - City of Hope |
10:15am | Break | Refreshments in Exhibit Hall |
10:45am | (03) Non-Small Cell Lung Cancer: Reframing the Treatment Landscape » Jennifer Dvorak, MSN, FNP-BC - University of CA, San Diego |
11:45am | Gather Lunch |
11:50am | Buffet Lunch & Non-CME/CE Presentation Sponsored by Incyte-Jakafi: Real-World Case Discussion WHEN TO INTERVENE WITH JAKAFIĀ® (ruxolitinib) In Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea » Rhonda Hewitt, NP - Stanford Cancer Center |
12:40pm | After Lunch Dessert Break in Exhibit |
1:00pm | (04) Pancreatic Adenocarcinoma: New Approaches in Treatment with a Focus on Targeted Therapy » Zev A. Wainberg, MD - UCLA School of Medicine |
2:00pm | Break | Refreshments in Exhibit Hall |
2:20pm | (05) Novel Therapies in Head and Neck Squamous Cell Carcinoma » Deborah Wong, MD, PhD - UCLA Medical Center |
3:20pm | (06) Cancer-Related Thrombosis: A Debate on the Best Way to Anticoagulate » Allison Schepers, PharmD - University of Michigan » Shawn Griffin, PharmD - UC Irvine |
4:35pm | Networking Reception |
Saturday, July 30, 2022 |
|
7:00am | Check-in & Breakfast Available in Exhibit Hall |
7:10am | Morning Symposium - Sponsored by Pfizer Oncology Clinical Trial Evidence for a CDK4/6 Inhibitor Combination Therapy Complemented by an Evaluation of Real-World Effectiveness » Kimberly C. Podsada, RN, MSN, NP-C, OCN - University of California, San Diego Moores Cancer Center |
8:00am | Horizon CME App Overview |
8:10am | Welcome, Introductions, & CE Housekeeping |
8:15am | (07) COVID-19 and Cancer: Where Are We Now? » Abigail Martin, MSN, NP-C - City of Hope Medical Center |
9:15am | (08) Expanding Therapeutic Options in Multiple Myeloma » Murali Janakiram, MD - City of Hope |
10:15am | Break | Refreshments in Exhibit Hall |
10:45am | (09) Treating B-cell Lymphoma in the Era of New Agents » Yi-Ping Wen, MSN, FNP-C - City of Hope |
11:45am | Gather Lunch |
11:50am | Buffet Lunch & Non-CE Symposium Presentation Sponsored by Taiho Oncology: LONSURF® (trifluridine and tipiracil) tablets: Oral chemotherapy for previously treated metastatic colorectal, gastric and gastroesophageal (GEJ) cancers » May Cho, MD |
12:40pm | Dessert Break in Exhibit Hall |
1:00pm | (10) Recent Progress in Cancer Drug Development: New Agents and New Strategies to Optimize Care » Julie Guglielmo, PharmD, BCOP - UC Davis |
2:00pm | Break | Refreshments in Exhibit Hall |
2:20pm | (11) MRD : Emerging Prognostic Biomarker in Hematologic Malignancies » Gary Schiller, MD - UCLA |
3:20pm | Closing Comments |